Navigation Links
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Date:6/17/2011

ty lawsuits and challenges to its intellectual property rights by actual or potential competitors or to its ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries including without limitation the litigation and claims referred to in Note 15—"Commitments and Contingencies" of the Notes to the Consolidated Financial Statements included in the Company's 2011 Form 10-K, and that any adverse judgments or settlements of such litigation, including product liability lawsuits, may be material to the Company;

(18) the possibility that our current estimates of the financial effect of certain announced product recalls could prove to be incorrect;

(19) whether any product recalls or product introductions result in litigation, agency action or material damages;

(20) the possibility of our loss of failure to supply claims by certain of the Company's customers, including CVS Pharmacy, Inc. and Caremark CVS Corporation, that, despite the formal discontinuation action by the Company of its products, the Company should compensate such customers for any additional costs they allegedly incurred for procuring products the Company did not supply;

(21) the series of putative class action lawsuits alleging violations of the federal securities laws by the Company and certain individuals, as more fully described in Note 15—"Commitments and Contingencies—Litigation and Governmental Inquiries" of the Notes to the Consolidated Financial Statements included in  the Company's 2011 Form 10-K;

(22) the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability or securities litigation;

(23) the informal inquir
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Par Pharmaceutical Reports Second Quarter 2008 Results
3. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
4. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
5. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
6. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
9. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 17, 2014 ... speakers and presentation topics that will be featured at ... Center,s Hamner Conference Center on December 3 and 4, ... biotechnology managers are invited to hear the following: ... , PhD UC San Diego Skaggs School ...
(Date:9/17/2014)... 2014 JH Technologies announces ... in Irvine. JH Technologies, a leader in sales ... announced an expanded partnership with Leica Microsystems into the ... image analysis solutions will be featured at the grand ... new showroom facility is located within the JH Technologies ...
(Date:9/17/2014)... 17, 2014 Hussey Copper , a ... antimicrobial copper, announces Gilmour Academy Ice Arena,s conversion ... EPA-registered antimicrobial solid touch surface to help protect against ... priced surface that kills greater than 99.9% of MRSA, ... 1 , ...
(Date:9/17/2014)... LAKE FOREST, California , 17 de ... BB: CYRX) ("la compañía"), principal proveedor mundial ... industria de las ciencias de la vida, ... una compañía de logística global con sede ... a su base de clientes Europa en ...
Breaking Biology Technology:In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 2JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 3Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5
... is the 11th in a series of articles on developing ... , Madison, Wis. - You've started your ... perhaps through investors. If you still need additional funding, what ... are basic financial principles to consider. , ,Most of ...
... Web-software services provider Zywave Inc. recently announced it ... being constructed in the Milwaukee County Research Park . ... real estate development circles, but the news is more than ... playing out, and an example of how a powerful business ...
... surging trend that has taken corporate boardrooms by ... pressure from myriad interest groups around the world ... and reporting. In 2005, according to Professor Michael ... CSR-related shareholder resolutions were filed on issues ranging ...
Cached Biology Technology:Early Stage: Step 11 - Other forms of finance 2Early Stage: Step 11 - Other forms of finance 3Early Stage: Step 11 - Other forms of finance 4Corporate venturing can nurture software success 2Corporate venturing can nurture software success 3Corporate venturing can nurture software success 4Corporate venturing can nurture software success 5Corporate venturing can nurture software success 6Corporate Social Responsibility - Burden, sham, or golden opportunity? 2Corporate Social Responsibility - Burden, sham, or golden opportunity? 3Corporate Social Responsibility - Burden, sham, or golden opportunity? 4Corporate Social Responsibility - Burden, sham, or golden opportunity? 5Corporate Social Responsibility - Burden, sham, or golden opportunity? 6Corporate Social Responsibility - Burden, sham, or golden opportunity? 7
(Date:9/17/2014)... Arts and Humanities has received a $260,000 grant from ... "The Boundaries of the Human in the Age of ... wide-ranging series of events aimed at exploring two compelling ... and researchers who are exploring the boundaries of our ... and the other involves the increasingly influential hypothesis that ...
(Date:9/17/2014)... "Nature has developed, very cleverly, some lessons on how ... design," said Joseph Shaw, director of the Optical Technology ... and structures at the nanoscale, we,ll discover them." , ... in August during a conference called "The Nature of ... Liang of the University of Arizona College of Optical ...
(Date:9/17/2014)... researchers have obtained the first partial genome sequence of ... found at the site of the Montsoriu Castle in ... is closely related to today,s Iberian pig. Researchers also ... modern Iberian pigs. , The study, published in ... pig species, and particularly on that of the Iberian ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Iberian pig genome remains unchanged after 5 centuries 2
... This release is available in Spanish . The ... Hesprides, will set out from Cdiz on Tuesday 15th November. The ... Council (CSIC) which aims to gauge the impact of global change ... off, which will take place at 11 a.m. on the east ...
... health professionals search for ways to combat the rise in ... own eating habits and whether she views her child ... whether her child consumes enough fruits and vegetables. ... College of Nursing looked at nearly 400 low-income women (black ...
... State University biologist Kenro Kusumi,s life in 1980 when, as ... his field notebook that he had found an Anolis egg ... with other memorabilia that document the influence that both his ... current pursuits in developmental biology. One such souvenir is a ...
Cached Biology News:Malaspina 2010, the biggest ever expedition on global change, sets sail 2Malaspina 2010, the biggest ever expedition on global change, sets sail 3Malaspina 2010, the biggest ever expedition on global change, sets sail 4Mothers' diets have biggest influence on children eating healthy 21 tale told is 2 tails gained 21 tale told is 2 tails gained 31 tale told is 2 tails gained 4
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Biology Products: